title: How we manage requests for recombinant factor VIIa (NovoSeven).
authors.affiliation: Department of Pathology, University of New Mexico, New Mexico, USA.
authors.forename: Prasad
authors.initials: P
authors.lastname: Mathew
authors.forename: Toby L
authors.initials: TL
authors.lastname: Simon
authors.forename: Kristin E
authors.initials: KE
authors.lastname: Hunt
authors.forename: Kendall P
authors.initials: KP
authors.lastname: Crookston
mesh_terms: D016527:Drug Costs; D004335:Drug and Narcotic Control / Q000379:methods*; D005168:Factor VII Deficiency / Q000151:congenital / Q000628:therapy; D015942:Factor VIIa / Q000191:economics / Q000627:therapeutic use*; D006470:Hemorrhage / Q000628:therapy; D006761:Hospitals; D006801:Humans; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D015942:Factor VIIa